Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine transdermal patch for perioperative analgesia in foot and ankle surgery
ChiCTR1800015249Phase 4Completed
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in postoperative pain, Foot and ankle disease and bunion deformity (HAV) comparing Flurbiprofen axetil intravenous injection, Oral celecoxib and Buprenorphine transdermal patch (3 arms). Primary endpoint: VAS score of perioperative period at 3 months. Started Nov 2017; status: completed.
02
Drugs
buprenorphineflurbiprofen axetilcelecoxib
03
Conditions
postoperative painFoot and ankle diseasebunion deformity (HAV)
Beyond the preview
Go deeper on ChiCTR1800015249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015249.